PPM exits Oxoid in £177m trade sale

European mid-market investor PPM Ventures has reported an IRR of 33 percent on the UK healthcare business it acquired from Cinven in 2000.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this